BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 28818550)

  • 1. ctDNA predicts clinical T1a to pathological T3a upstaging after partial nephrectomy.
    Park JS; Kim H; Jang WS; Kim J; Ham WS; Lee ST
    Cancer Sci; 2024 May; 115(5):1680-1687. PubMed ID: 38475661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of pT3a staging subclassifications in renal cell carcinoma: Not all pT3a are equal.
    Rezaee ME; Pallauf M; Fletcher SA; Pavlovich CP; Baraban E; Ged Y; Singla N
    Urol Oncol; 2024 Apr; 42(4):119.e23-119.e29. PubMed ID: 38355353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The preoperative predictive factors for pathological T3a upstaging and positive surgical margin of clinical T1 renal cell carcinoma.
    Çil G; Yilmaz M; Sahin Y; Ulus I; Canıtez IO; Kandıralı IE
    Actas Urol Esp (Engl Ed); 2024 May; 48(4):311-318. PubMed ID: 38369290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse pathologic features impact survival outcomes for small renal masses following nephrectomy.
    Khaleel S; Truong H; Jiang S; K-Lee P; Davelman B; Gordon D; Benfante N; Arora A; Ostrovnaya I; Tickoo S; Coleman J; Hakimi AA; Russo P
    Urol Oncol; 2023 Sep; 41(9):391.e5-391.e11. PubMed ID: 37423816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parenchymal obliteration by renal masses: Functional and oncologic implications.
    Kazama A; Munoz-Lopez C; Attawettayanon W; Boumitri M; Maina E; Lone Z; Rathi N; Lewis K; Campbell RA; Palacios DA; Kaouk J; Haber GP; Haywood S; Almassi N; Weight CJ; Remer EM; Ward R; Nowacki AS; Campbell SC
    Urol Oncol; 2024 Aug; 42(8):247.e11-247.e19. PubMed ID: 38729867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of preoperative radiographic perinephric fat features in renal cell carcinoma patients undergoing surgery.
    Kuo YR; Lee YC; Wang CT; Liu WC; Ou CH; Lin KC; Cheng TH; Jan HC; Hu CY
    Asian J Surg; 2024 May; 47(5):2188-2194. PubMed ID: 38383186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Real-world study on the characteristics, post-nephrectomy journey, and outcomes of patients with early-stage renal cell carcinoma based on risk groups.
    Karam JA; Bhattacharya R; Ogbomo A; Gautam S; Yu R; Sundaram M; Imai K; Chhabra J; Haas NB
    Cancer Med; 2024 Jun; 13(11):e7247. PubMed ID: 38826126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary lesion after surgery for renal cancer: progression or new primary?
    Cignoli D; Bandiera A; Rosiello G; Castorina R; Re C; Cei F; Musso G; Belladelli F; Freschi M; Lucianò R; Raggi D; Negri G; Necchi A; Salonia A; Montorsi F; Larcher A; Capitanio U
    World J Urol; 2024 May; 42(1):361. PubMed ID: 38814376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computer tomography-based shape of tumor contour and texture of tumor heterogeneity are independent prognostic indicators for clinical T1b-T2 renal cell carcinoma.
    Song B; Hwang SI; Lee HJ; Lee H; Oh JJ; Lee S; Hong SK; Byun SS; Kim JK
    World J Urol; 2023 Oct; 41(10):2723-2734. PubMed ID: 37530807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Partial nephrectomy margin imaging using structured illumination microscopy.
    Wang M; Tulman DB; Sholl AB; Mandava SH; Maddox MM; Lee BR; Quincy Brown J
    J Biophotonics; 2018 Mar; 11(3):. PubMed ID: 28834287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncologic Outcomes and Predictors in Patients with Stage PT3aNxM0 Renal Cell Carcinoma Following Radical Nephrectomy.
    Soltani MH; Dadpour M; Goodarzi M; Khabazian R; Narouie B; Borumandnia N; Madani MH
    Urol Res Pract; 2023 Jan; 49(1):25-32. PubMed ID: 37877835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Extrarenal Invasion Patterns and Tumor Size with the Differences in Survival Outcomes of T3a Renal Cell Carcinoma: A Proposal Modified T3a Stage System is Needed.
    Wu X; Wang Q; Wang Z; Zhao X; Xu X
    Int J Gen Med; 2022; 15():367-378. PubMed ID: 35027844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Evaluation of the Site of Invasion in Pathological Stage T3a Renal Cell Carcinoma.
    Lai GS; Li JR; Wang SS; Chen CS; Yang CK; Hung SC; Cheng CL; Ou YC; Chiu KY
    In Vivo; 2021; 35(2):1083-1089. PubMed ID: 33622905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple Patterns of Perirenal Fat Invasion Are Associated With a Poorer Prognosis Compared With Isolated Invasion: A Proposal for a Revision of T3aN0M0 TNM Staging System.
    Wang Z; Yu K; Zhu Y; Feng C; Liu C; Liu S; Wang J; Zeng X
    Front Oncol; 2020; 10():336. PubMed ID: 32219068
    [No Abstract]   [Full Text] [Related]  

  • 15. Prognostic significance of the sub-classification of stage pT3a renal tumors by perinephric and sinus fat invasion.
    Zhu D; Cao J; Zhi C; Guo T; Li Y; Lang Z; Li G
    Oncol Lett; 2020 Mar; 19(3):1721-1726. PubMed ID: 32194664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Prevalence of Benign Pathologic Findings After Partial Nephrectomy With Preoperative Imaging Patterns in the United States From 2007 to 2014.
    Kim JH; Li S; Khandwala Y; Chung KJ; Park HK; Chung BI
    JAMA Surg; 2019 Mar; 154(3):225-231. PubMed ID: 30516801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accurate Risk Assessment of Patients with Pathologic T3aN0M0 Renal Cell Carcinoma.
    Oh JJ; Lee JK; Do Song B; Lee H; Lee S; Byun SS; Lee SE; Hong SK
    Sci Rep; 2018 Sep; 8(1):13914. PubMed ID: 30224666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. National trends of preoperative imaging modalities before partial nephrectomy for renal masses in the U.S. from 2007-2015.
    Kim JH; Li S; Khandwala Y; Del Giudice F; Chung KJ; Park HK; Chung BI
    Can Urol Assoc J; 2019 Mar; 13(3):E89-E94. PubMed ID: 30169151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perinephric and Sinus Fat Invasion in Stage pT3a Tumors Managed by Partial Nephrectomy.
    Mouracade P; Dagenais J; Chavali JS; Kara O; Nelson RJ; Maurice MJ; Reese J; Rini BI; Kaouk JH
    Clin Genitourin Cancer; 2018 Oct; 16(5):e1077-e1082. PubMed ID: 28818550
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.